Edesa Biotech
EDSA
9 hedge funds and large institutions have $36K invested in Edesa Biotech in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
14% less capital invested
Capital invested by funds: $42K → $36K (-$6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.55K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$6.18K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
1
Advisor Group
Phoenix,
Arizona
| $26K | – | – | – |
|
|
WAS
2
WESPAC Advisors SoCal
Pasadena,
California
| $2K | – | – | – |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$2.55K | +7 | New |
|
|
ASN
4
Advisory Services Network
Atlanta,
Georgia
| $1K | – | – | – |
|
5
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
CFD
6
Creative Financial Designs
Kokomo,
Indiana
| $1K | – | – | – |
|
|
EDRH
7
Edmond de Rothschild Holding
Chambesy,
Switzerland
| $1K | – | – | – |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
9
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | +$2.18K | +6 | New |
|
|
10
UBS Group
Zurich,
Switzerland
| – | -$6.18K | -17 | Closed |
|
|
11
Creative Planning
Overland Park,
Kansas
| – | -$1K | -2 | Closed |
|
EDSA Hedge Fund Activity: Q3 2017 in Review
9 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q3 2017, worth a combined $36K — down 14% from $42K a quarter earlier.
Fund positioning in EDSA was balanced in Q3 2017: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $2.55K. The largest seller was UBS Group, exiting entirely with an estimated $6.18K sold.
- 9 institutional investors held Edesa Biotech (EDSA) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $36K of Edesa Biotech stock for Q3 2017, down 14% quarter-over-quarter.
- 2 funds opened new Edesa Biotech positions in Q3 2017 and 2 closed out, a net change of 0 holders.
- The largest Edesa Biotech buyer in Q3 2017 was Royal Bank of Canada, an estimated $2.55K added.
- The largest Edesa Biotech seller in Q3 2017 was UBS Group, an estimated $6.18K sold.
Based on aggregated 13F filings for Q3 2017.